Summary
We have developed a screening strategy and technology to produce monoclonal antibodies with specificity for human lung cancer cells. Mice and rats were immunized with well-characterized tissue culture lines of human small cell lung cancer (SCLC), mouse myeloma x spleen hybrids formed by the technique of Kohler and Milstein, and the resulting culture fluids were screened for antibody binding phenotype using a radioimmunoassay. To facilitate testing large numbers of culture fluids, a 96-well, microtiter based, resuable, replicating device was designed. Using this, many hybridoma culture fluids were replica plated for antibody binding tests on a series of human target cell plates. Hybrids producing antibodies that reacted with the immunizing SCLC line and another independent SCLC line, but not with autologous B-lymphoblastoid cells derived from one of the patients, were identified, selected, and then repeatedly recloned using the same screening strategy. With this technology, hybridomas representing less than 0.5% of all hybrids generated could be isolated and stable antibody producing cultures derived. Such antibodies reacted with a panel of well-characterized SCLC lines and SCLC samples taken directly from patients but not with a variety of normal tissues. Using these antibodies we can demonstrate: tumor cell contamination of bone marrow specimens, marked heterogeneity of antigen expression on cells within individual SCLC lines and individual patients, and inhibition of clonal growth of SCLC lines in soft agarose assays. All of these findings have potential clinical and cell biologic application.
Similar content being viewed by others
References
Kohler, G.; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497; 1975.
Koprowski, H.; Steplewski, Z.; Herlyn, D.; Herlyn, M. Study of antibodies against human melanoma produced by somatic cell hybrids. Proc. Natl. Acad. Sci. USA 75: 3405–3409; 1978.
Yeh, M. Y.; Hellstrom, I.; Brown, J. P.; Warner, G. A.; Hansen, J. A.; Hellstrom, K. E., Cell surface antigens of human melanoma identified by monoclonal antibody. Proc. Natl. Acad. Sci. USA 76: 2927–2931; 1979.
Dippold, W. G.; Lloyd, K. O.; Li, L. T. C.; Ikeda, H.; Oettgen, H. F.; Old, L. J. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc. Natl. Acad. Sci. USA 77: 6114–6118; 1980.
Imai, K.; Ng, A.; Ferrone, S. Characterization of monoclonal antibodies to human melanoma-associated antigens. J. Natl. Cancer Inst. 66: 489–496; 1981.
Magnani, J. L.; Brochkaus, M.; Smith, D. F.; Ginsburg, V.; Blaszczyk, M.; Mitchell, K. F.; Steplewski, Z.; Koprowski, H. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212: 55–56; 1981.
Kennett, R. H.; Gilbert, F. Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain. Science 203: 1120–1121; 1979.
Schlom, J.; Wunderlich, D.; Teramoto, Y. A. Generation of human monoclonal antibodies reactive with human mammary carcinoma cells. Proc. Natl. Acad. Sci. USA 6841–6845; 1980.
Levy, R.; Dilley, J.; Fox, R. I.; Warnke, R. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc. Natl. Acad. Sci. USA 76: 6552–6556; 1979.
Ritz, J.; Pesando, J. M.; Notis-McConarty, J.; Lazarus, H.; Schlossman, S. F. A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature 283: 583–585; 1980.
Nadler, L. M.; Stashenko, P.; Hardy, R.; Schlossman, S. F. A monoclonal antibody defining a lymphoma-associated antigen in man. J. Immunol. 125: 570–577; 1980.
Schnegg, J. F.; Diserens, A. C.; Carrel, S.; Accolia, R. S.; de Tribolet, N. Human glioma-associated antigens detected by monoclonal antibodies. Cancer Res. 41: 1209–1213; 1981.
Cuttitta, F.; Rosen, S.; Gazdar, A. F.; Minna, J. D. Monoclonal antibodies which demonstrate specificity for several types of human lung cancer. Proc. Natl. Acad. Sci. USA 78: 4591–4595; 1981.
Minna, J. D.; Higgins, G. A.; Glatstein, E. J. Cancer of the lung. DeVita, V. T.; Hellman, S.; Rosenberg, S. A. eds. Principles and practice of oncology. Philadelphia: J. B. Lippincott; 1981: 396–473.
Gazdar, A. F.; Carney, D. N.; Guccion, J. G.; Baylin, S. B. Small cell carcinoma of the lung; cellular origin and relationship to other pulmonary tumors. Greco, F. A.; Oldham, R.; Bunn, P. A. Jr., eds. Small cell lung cancer. New York: Grune & Stratton; 1981: 145–175.
Gazdar, A. F.; Carney, D. N.; Russell, E. K.; Sims, H. L.; Baylin, S. B.; Bunn, P. A. Jr.: Guccion, J. G.; Minna, J. D. Establishment of continuous clonable culture of small-cell carcinoma of the lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res. 40: 3502–3507; 1980.
Carney, D. N.; Gazdar, A. F.; Minna, J. D. Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small-cell carcinoma of the lung. Cancer Res. 40: 1820–1823; 1980.
Simms, E.; Gazdar, A. F.; Abrams, P. G.; Minna, J. D. Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor-supplemented medium. Cancer Res. 40: 4356–4363; 1980.
Carney, D. N.; Bunn, P. A. Jr.; Gazdar, A. F.; Pagan, J. A.; Minna, J. D. Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc. Natl. Acad. Sci. USA 78: 3185–3189; 1981.
Gazdar, A. F.; Zweig, M. H.; Carney, D. N.; Van Steirtegh, A. C.; Baylin, S. B.; Minna, J. D. Level of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. Cancer Res. 41: 2773–2777; 1981.
Whang-Peng, J.; Kao-Shan, C. S.; Lee, E. C.; Bunn, P. A.; Carney, D. N.; Gazdar, A. F.; Minna, J. D. A specific chromosome defect associated with human small cell lung cancer: deletion 3p(14–23). Science. In press.
Kearney, J. F.; Radbruch, A.; Liesegang, B.; Rajewsky, K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J. Immunol. 123: 1548–1550; 1979.
Galfre, G.; Howe, S. C.; Milstein, C.; Butcher, G. W.; Howard, J. D.: Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266: 550–552; 1977.
Kennett, R. H.; Denis, K. A.; Tung, A. S.; Klinman, N. R. Hybrid plasmacytoma production: fusions with adult spleen cells, monoclonal spleen fragments, neonatal spleen cells and human spleen cells. Curr. Top. Microbiol. Immunol. 81: 77–91; 1978.
Nowinski, R. C.; Lostrom, M. E.; Tam, M. R.; Stone, M. R.; Burnette, W. N. The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses. Virology 93: 111–126; 1979.
Brown, J. P.; Tamerius, J. D.; Hellstrom, I. Indirect125I-labeled protein A assay for monoclonal antibodies to cell surface antigens. J. Immunol. Methods 31: 201–209; 1979.
Stocker, J. W.; Heusser, C. H. Methods for binding cells to plastic: application to a solid-phase radioimmunoassay for cell-surface antigens. J. Immunol. Methods 26: 87–95; 1979.
Hunter, W. M.; Greenwood, F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194: 495–496; 1962.
Hsu, S. M.; Raine, L.; Fanger, H. The use of avidin-biotin-peroxidase comples (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577–581; 1981.
Bell, C. E.; Seetharam, S.; McDaniel, R. C. Endodermally-derived and neural crest-derived differentiation antigens expressed by a human lung tumor. J. Immunol. 116: 1236–1243; 1976.
Lieber, M.; Smith, B.; Szakal, A.; Nelson-Rees, W.; Todaro, G. A continuous tumor cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer 17: 62–70; 1976.
Schlesinger, H. R.; Gerson, J. M.; Moorhead, P. S.; Maguire, H.; Hummeler, K. Establishment and characterization of human neuroblastoma cell lines. Cancer Res. 36: 3094–3100; 1976.
Soule, H. D.; Vasquez, J.; Long, A.; Albert, S.; Brenner, M. B. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51: 1409–1416; 1978.
Engel, L. W.; Young, N. A.; Tralka, T. S.; Lippman, M. E.; O'Brien, S. J.; Joyce, M. J. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer. Res. 38: 3352–3364; 1978.
Coakham, H. B.; Kornblith, P. L.; Quindlen, E. A.; Pollock, L. A.; Wood, W. C.; Hartnett, L. C. Autologous humoral response to human gliomas and analysis of certain cell surface antigens: In vitro study with the use of microcytotoxicity and immune adherence assays. J. Natl. Cancer Inst. 64: 223–233; 1980.
Nilsson, K.; Bennich, H.; Johansson, S. G. O.; Ponten, J. Established immunoglobulin producting myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin. Exp. Immunol. 7: 477–489; 1970.
Minowada, J.; Ohnuma, T.; Moore, G. E. Rosetteforming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49: 891–895; 1972.
Gazdar, A. F.; Carney, D. N.; Bunn, P. A.; Russell, E. K.; Jaffe, E. S.; Schecter, G. P.; Guccion, J. G. Mitogen requirements for the in vitro propagation of cutanous T-cell lymphomas. Blood 55: 409–417; 1980.
Weiss, M. C.; Ephrussi, B.; Scaletta, L. J. Loss of T-antigen from somatic hybrids between mouse cells and SV40-transformed human cells. Proc. Natl. Acad. Sci. USA 59: 1132–1135; 1968.
Felluga, B.; Claude, A.; Mrena, E. Electron microscope observations on virus particles associated with a transplantable renal adenocarcinoma in BALB-cf-cd mice. J. Natl. Cancer Inst. 43: 319–324; 1969.
Littlefield, J. W. The use of drug resistant markers to study the hybridization of mouse fibroblasts. Exp. Cell Res. 41: 190–196; 1966.
Gillan, F. D.; Roufa, J. D.; Beaudet, A. L.; Caskey, C. T. 8-Azaguanine resistance in mammalian cells. I. Hypozxanthine-guanine phosphoribosyl transferase. Genetics 72: 239–252; 1972.
Olsson, L.; Kaplan, H. S. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc. Natl. Acad. Sci. USA 77: 5429–5431; 1980.
Koprowski, H.; Herlyn, M.; Steplewski, Z.; Sears, H. F. Specific antigen in serum of patients with colon carcinoma. Science 212: 53–55; 1981.
Ballou, B.; Levine, G.; Hakala, T. R.; Solter, S. Tumor location detected with radioactively labeled monoclonal antibody and external scintigraphy. Science 206: 844–847; 1979.
Nadler, L. M.; Stashenko, P.; Hardy, P.; Kaplan, W. D.; Button, L. N.; Kufe, D. W.; Antman, K. W.; Schlossman, S. F. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res. 40: 3147–3154; 1980.
Miller, R. A.; Levy, R. In vivo effects of murine hybridoma monoclonal antibody in human T cell neoplasms. Clin. Res. 29: 529A; 1981.
Olsnes, S. Directing toxins to cancer cells. Nature 290: 84; 1981.
Belles-Isles, M.; Page, M. Anti-oncofoetal proteins for targeting cytotoxic drugs. Int. J. Immunopharmacol. 3: 97–102; 1981.
Leserman, L. D.; Machy, P.; Barbet, J. Cell-specific drug transfer from liposomes bearing monoclonal antibodies. Nature 293: 226–228; 1981.
Author information
Authors and Affiliations
Additional information
This symposium was supported in part by the following organizations: Bethesda Research Laboratories, Cetus Corporation, Hybritech Incorporated, MAB-Monoclonal Antibodies, Inc., National Capital Area Branch of the Tissue Culture Association, New England Nuclear Corporation, and Ortho Pharmaceutical Corporation.
Rights and permissions
About this article
Cite this article
Minna, J.D., Cuttitta, F., Rosen, S. et al. Methods for production of monoclonal antibodies with specificity for human lung cancer cells. In Vitro 17, 1058–1070 (1981). https://doi.org/10.1007/BF02618603
Issue Date:
DOI: https://doi.org/10.1007/BF02618603